Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Mingxi Li, Yifei Ren, Zhen Qin Aw, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies
Wenyuan Shang, Xiujun Hu, Xiaoman Lin, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 424-424
Open Access | Times Cited: 3
Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants
Lei He, Qian Wu, Zhaoyong Zhang, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 3
Localized and delocalized topological modes of heat
Jiaxin Li, Chengxin Xu, Zifu Xu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 35
Closed Access | Times Cited: 3
Self-sacrificing and self-supporting biomass carbon anode–assisted water electrolysis for low-cost hydrogen production
Yuming Huang, Wei Zhou, Liang Xie, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 47
Open Access | Times Cited: 3
Biomimetic Nanotechnology for SARS-CoV-2 Treatment
Shuo Li, Xue Liu, Gang Liu, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 596-596
Open Access | Times Cited: 8
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 8
Nanobodies with cross-neutralizing activity provide prominent therapeutic efficacy in mild and severe COVID-19 rodent models
Qiuxue Han, Shen Wang, Zhenshan Wang, et al.
Virologica Sinica (2023) Vol. 38, Iss. 5, pp. 787-800
Open Access | Times Cited: 7
Screening, Expression and Identification of Nanobody Against Monkeypox Virus A35R
Ni Meng, Xiaolong Cheng, Mengyao Sun, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 7173-7181
Open Access | Times Cited: 6
Engineered Multivalent Nanobodies Efficiently Neutralize SARS-CoV-2 Omicron Subvariants BA.1, BA.4/5, XBB.1 and BQ.1.1
Jiali Wang, Bingjie Shi, Hanyi Chen, et al.
Vaccines (2024) Vol. 12, Iss. 4, pp. 417-417
Open Access | Times Cited: 2
A nanobody interaction with SARS-COV-2 Spike allows the versatile targeting of lentivirus vectors
Ayna Alfadhli, Timothy A. Bates, Robin Lid Barklis, et al.
Journal of Virology (2024) Vol. 98, Iss. 9
Open Access | Times Cited: 2
Biodegradable magnesium based metal materials inhibit the growth of cervical cancer cells
Xiaojing Nie, Lei Wang, Zhenqin Zhao, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Arctic halogens reduce ozone in the northern mid-latitudes
Rafael P. Fernández, Lucas Berná, Orlando Tomazzeli, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 39
Open Access | Times Cited: 2
Facilitating and restraining virus infection using cell-attachable soluble viral receptors
Heng Zhang, Zhengli Wang, Huong T. T. Nguyen, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 45
Open Access | Times Cited: 1
Discovery of broad-spectrum high-affinity peptide ligands of spike protein for the vaccine purification of SARS-CoV-2 and Omicron variants
Jing Ma, Yongdong Huang, Guodong Jia, et al.
International Journal of Biological Macromolecules (2024) Vol. 283, pp. 137059-137059
Closed Access | Times Cited: 1
Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1
Haodi Dong, Runhong Zhou, Jing Chen, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 11, pp. e1012625-e1012625
Open Access | Times Cited: 1
Current status of BAFF targeting immunotherapy in B-cell neoplasm
Nami Tagami, Junichiro Yuda, Yasuyuki Goto
International Journal of Clinical Oncology (2024)
Open Access | Times Cited: 1
Nanobodies against SARS-CoV-2 reduced virus load in the brain of challenged mice and neutralized Wuhan, Delta and Omicron Variants
María F. Pavan, Marina Bok, Rafael Betanzos San Juan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
The cAMP receptor protein (CRP) enhances the competitive nature of Salmonella Typhimurium
Kirti Sawant, Ravindranath Shashidhar
Archives of Microbiology (2023) Vol. 205, Iss. 5
Closed Access | Times Cited: 3
SARS-CoV-2 proteins structural studies using synchrotron radiation
Maksim N. Kosenko, G. S. Onkhonova, Ivan M. Susloparov, et al.
Biophysical Reviews (2023) Vol. 15, Iss. 5, pp. 1185-1194
Open Access | Times Cited: 2
Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/ Iraq
Sevan Omer Majed, Paywast Jamal Jalal, Mohammed Hassan Fatah, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 11, pp. 56-63
Open Access | Times Cited: 2
Iterative In Silico Screening for Optimizing Stable Conformation of Anti-SARS-CoV-2 Nanobodies
Wenyuan Shang, Xiujun Hu, Xiaoman Lin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The 2 nd China Vaccinology Integrated Innovation & Teaching Development Conference: Promoting the construction of vaccinology discipline system
Yingqi Chen, Yuelong Shu, Hui Zheng, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Terahertz bistatic three-dimensional computational imaging of hidden objects through random media
Quanchun Yu, He Cai, Xianli Zhu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization
Ran Zhang, Lan Huang, Xiaohan Zhang, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 5, pp. 1559-1570
Closed Access
A Nanobody Interaction with SARS-CoV-2 Spike Allows the Versatile Targeting of Lentivirus Vectors
Ayna Alfadhli, Timothy A. Bates, Robin Lid Barklis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Scroll to top